SCHEMBL19082362

SCHEMBL19082362

c1ccc2c(-c3c4ccccc4c(-c4ccc(-c5ccc6c(c5)sc5cc7sc8ccc9ccccc9c8c7cc56)c5ccccc45)c4ccccc34)cccc2c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 2/20 0.34
ACMSD Q8TDX5 1/20 0.34
CA12 O43570 4/20 0.33
CA1 P00915 4/20 0.33
CA2 P00918 4/20 0.33
CA9 Q16790 4/20 0.33
NQO2 P16083 2/20 0.33
NQO1 P15559 1/20 0.33
ALOX5 P09917 1/20 0.32
SOS1 Q07889 1/20 0.32
HDAC8 Q9BY41 1/20 0.31
HDAC6 Q9UBN7 1/20 0.31
PRKDC P78527 1/20 0.31
EDNRB P24530 1/20 0.31
EDNRA P25101 1/20 0.31
CYP1A1 P04798 2/20 0.30
CYP1B1 Q16678 2/20 0.30
CYP1A2 P05177 2/20 0.30
S1PR4 O95977 1/20 0.30
S1PR5 Q9H228 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082358 0.96 MCL1 (0.35) MCL1ACMSDCA12CA1CA2
SCHEMBL17944378 0.93 MCL1 (0.37) MCL1ACMSDCA12CA1CA2
SCHEMBL19082255 0.92 CA12 (0.33) MCL1CA12CA1CA2CA9
SCHEMBL19082326 0.92 NQO2 (0.32) MCL1NQO2NQO1SOS1CYP1A1
SCHEMBL19082379 0.91 PIM1 (0.32) CA12CA1CA2CA9NQO2
SCHEMBL19082109 0.90 NQO2 (0.34) MCL1ACMSDCA12CA1CA2
SCHEMBL19110236 0.90 ALOX5 (0.35) MCL1ACMSDCA12CA1CA2
SCHEMBL19082184 0.89 KDM4E (0.33) MCL1NQO2NQO1SOS1CYP1A1
SCHEMBL17944646 0.89 ALOX5 (0.41) MCL1ACMSDCA12CA1CA2
SCHEMBL17944939 0.89 MCL1 (0.38) MCL1ACMSDCA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 MCL1 1139/4885ACMSD 1586/4885CA12 1240/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 MCL1 1139/4885ACMSD 1586/4885CA12 1240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.